Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
More news for Monday, Feb. 5
By
Kimberly Bonvissuto
Feb 05, 2024
Takeaways from NIC MAP’s fourth-quarter fundamentals release … Use of Medicaid wraparound services by dually eligible individuals varies by service, state … StartUp Health launches global Alzheimer’s...
New fluorescence imaging technique makes toxic Alzheimer’s proteins ‘glow’ for earlier-than-ever...
By
Aaron Dorman
Feb 08, 2024
An innovative sensor was able to detect toxic beta amyloid proteins, which cause Alzheimer’s, with a new fluorescence “fingerprint” technique.
More news for Friday, Oct. 7
By
Kimberly Bonvissuto
Oct 07, 2022
WHO sets 2030 deadline to find Alzheimer’s cure … Report informs how to improve housing for older adults while addressing inequities … Most Americans want strong, sustainable Medicaid program …...
Financial hardship drives unhappiness in people living with dementia, study finds
By
Kristen Fischer
Jan 05, 2024
A new study in the Journal of the American Geriatrics Society reveals just how tough it can be financially to live with dementia.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
New framework for national plan on aging aims to ease access to LTSS for older adults
By
Kimberly Bonvissuto
May 31, 2024
Creating a more person-centered, accessible system of care to enable older adults to more easily connect with long-term services and supports is part of a strategic framework for a national plan on aging...
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.